Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Cancer Biologics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Celgene
Amgen
Roche
Johnson & Johnson
Bayer
Merck
Eli Lilly
Novartis
Pfizer
By Type:
Vaccines
Others
Cell and Gene Therapy
Monoclonal Antibodies
By Application:
Clinics
Others
Hospitals
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Cancer Biologics Market Overview 2018-2029
-
1.1 China Cancer Biologics Industry Development Overview
-
1.2 China Cancer Biologics Industry Development History
-
1.3 China Cancer Biologics Industry Market Size (2018-2029)
-
1.4 China Cancer Biologics Market Analysis by Type from Production Side
-
1.4.1 China Cancer Biologics Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
1.4.2 China Cancer Biologics Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Cancer Biologics Production Volume, Production Value and Growth Rate of Cell and Gene Therapy (2018-2029)
-
1.4.4 China Cancer Biologics Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.5 China Cancer Biologics Market Analysis by Application from Consumption End
-
1.5.1 China Cancer Biologics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.5.2 China Cancer Biologics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Cancer Biologics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.6 China Cancer Biologics Market Analysis by Region
-
1.6.1 North China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Cancer Biologics Market Size and Growth Rate from 2018-2029
Chapter 2 China Cancer Biologics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Cancer Biologics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Cancer Biologics Market Status and Competition Analysis in 2023
-
2.2.3 China Cancer Biologics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Cancer Biologics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Cancer Biologics Industry Development
Chapter 3 Cancer BiologicsIndustry Chain Analysis
-
3.1 Cancer Biologics Industry Chain
-
3.2 Cancer Biologics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Cancer Biologics Market
-
3.3 Cancer Biologics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Cancer Biologics Market
Chapter 4 China Cancer Biologics Market, by Type
-
4.1 China Cancer Biologics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Cancer Biologics Total Production Volume and Growth Rate from Production Side
-
4.5 China Cancer Biologics Production Volume and Growth Rate, by Type
-
4.5.1 China Cancer Biologics Production Volume and Growth Rate of Vaccines
-
4.5.2 China Cancer Biologics Production Volume and Growth Rate of Others
-
4.5.3 China Cancer Biologics Production Volume and Growth Rate of Cell and Gene Therapy
-
4.5.4 China Cancer Biologics Production Volume and Growth Rate of Monoclonal Antibodies
Chapter 5 China Cancer Biologics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Cancer Biologics Total Market Size and Growth Rate from Consumption End
-
5.5 China Cancer Biologics Market Size and Growth Rate, by Application
-
5.5.1 China Cancer Biologics Market Size and Growth Rate of Clinics
-
5.5.2 China Cancer Biologics Market Size and Growth Rate of Others
-
5.5.3 China Cancer Biologics Market Size and Growth Rate of Hospitals
Chapter 6 China Cancer Biologics Market, by Region
-
6.1 China Cancer Biologics Production Volume and Production Value, by Region
-
6.2 China Cancer Biologics Sales Volume and Sales Value, by Region
Chapter 7 North China Cancer Biologics Market Analysis
-
7.1 North China Cancer Biologics Market, by Type
-
7.2 North China Cancer Biologics Market, by Application
Chapter 8 Central China Cancer Biologics Market Analysis
-
8.1 Central China Cancer Biologics Market, by Type
-
8.2 Central China Cancer Biologics Market, by Application
Chapter 9 South China Cancer Biologics Market Analysis
-
9.1 South China Cancer Biologics Market, by Type
-
9.2 South China Cancer Biologics Market, by Application
Chapter 10 East China Cancer Biologics Market Analysis
-
10.1 East China Cancer Biologics Market, by Type
-
10.2 East China Cancer Biologics Market, by Application
Chapter 11 Northeast China Cancer Biologics Market Analysis
-
11.1 Northeast China Cancer Biologics Market, by Type
-
11.2 Northeast China Cancer Biologics Market, by Application
Chapter 12 Southwest China Cancer Biologics Market Analysis
-
12.1 Southwest China Cancer Biologics Market, by Type
-
12.2 Southwest China Cancer Biologics Market, by Application
Chapter 13 Northwest China Cancer Biologics Market Analysis
-
13.1 Northwest China Cancer Biologics Market, by Type
-
13.2 Northwest China Cancer Biologics Market, by Application
Chapter 14 Company Profiles
-
14.1 Celgene
-
14.1.1 Celgene Company Profile
-
14.1.2 Celgene Cancer Biologics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Amgen
-
14.2.1 Amgen Company Profile
-
14.2.2 Amgen Cancer Biologics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Roche
-
14.3.1 Roche Company Profile
-
14.3.2 Roche Cancer Biologics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Johnson & Johnson
-
14.4.1 Johnson & Johnson Company Profile
-
14.4.2 Johnson & Johnson Cancer Biologics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bayer
-
14.5.1 Bayer Company Profile
-
14.5.2 Bayer Cancer Biologics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Merck
-
14.6.1 Merck Company Profile
-
14.6.2 Merck Cancer Biologics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Profile
-
14.7.2 Eli Lilly Cancer Biologics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Novartis
-
14.8.1 Novartis Company Profile
-
14.8.2 Novartis Cancer Biologics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Pfizer
-
14.9.1 Pfizer Company Profile
-
14.9.2 Pfizer Cancer Biologics Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Cancer Biologics Industry Research Conclusions
-
15.2 Cancer Biologics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Cancer Biologics Industry Market Size (2018-2029)
-
Figure China Cancer Biologics Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
Figure China Cancer Biologics Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Cancer Biologics Production Volume, Production Value and Growth Rate of Cell and Gene Therapy (2018-2029)
-
Figure China Cancer Biologics Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure China Cancer Biologics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure China Cancer Biologics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Cancer Biologics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure North China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
Figure Central China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
Figure South China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
Figure East China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Cancer Biologics Market Size and Growth Rate from 2018-2029
-
Figure Cancer Biologics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Cancer Biologics Market Share by Type in 2018
-
Figure China Cancer Biologics Market Share by Type in 2023
-
Figure China Cancer Biologics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Cancer Biologics Production Volume and Growth Rate of Vaccines (2018-2023)
-
Figure China Cancer Biologics Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Cancer Biologics Production Volume and Growth Rate of Cell and Gene Therapy (2018-2023)
-
Figure China Cancer Biologics Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Figure China Cancer Biologics Market Share by Application in 2018
-
Figure China Cancer Biologics Market Share by Application in 2023
-
Figure China Cancer Biologics Total Market Size and Growth Rate from Consumption End
-
Figure China Cancer Biologics Market Size and Growth Rate of Clinics (2018-2023)
-
Figure China Cancer Biologics Market Size and Growth Rate of Others (2018-2023)
-
Figure China Cancer Biologics Market Size and Growth Rate of Hospitals (2018-2023)
-
Table China Cancer Biologics Production Volume by Region (2018-2023)
-
Table China Cancer Biologics Production Volume Share by Region (2018-2023)
-
Figure China Cancer Biologics Production Volume Share by Region (2018-2023)
-
Table China Cancer Biologics Production Value by Region (2018-2023)
-
Table China Cancer Biologics Production Value Share by Region (2018-2023)
-
Figure China Cancer Biologics Production Value Share by Region (2018-2023)
-
Table China Cancer Biologics Sales Volume by Region (2018-2023)
-
Table China Cancer Biologics Sales Volume Share by Region (2018-2023)
-
Figure China Cancer Biologics Sales Volume Share by Region (2018-2023)
-
Table China Cancer Biologics Sales Value by Region (2018-2023)
-
Table China Cancer Biologics Sales Value Share by Region (2018-2023)
-
Figure China Cancer Biologics Sales Value Share by Region (2018-2023)
-
Table North China Cancer Biologics Production Volume by Type (2018-2023)
-
Table North China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Figure North China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Table North China Cancer Biologics Sales Volume by Application (2018-2023)
-
Table North China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Figure North China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Table Central China Cancer Biologics Production Volume by Type (2018-2023)
-
Table Central China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Figure Central China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Table Central China Cancer Biologics Sales Volume by Application (2018-2023)
-
Table Central China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Figure Central China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Table South China Cancer Biologics Production Volume by Type (2018-2023)
-
Table South China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Figure South China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Table South China Cancer Biologics Sales Volume by Application (2018-2023)
-
Table South China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Figure South China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Table East China Cancer Biologics Production Volume by Type (2018-2023)
-
Table East China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Figure East China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Table East China Cancer Biologics Sales Volume by Application (2018-2023)
-
Table East China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Figure East China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Cancer Biologics Production Volume by Type (2018-2023)
-
Table Northeast China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Table Northeast China Cancer Biologics Sales Volume by Application (2018-2023)
-
Table Northeast China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Cancer Biologics Production Volume by Type (2018-2023)
-
Table Southwest China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Table Southwest China Cancer Biologics Sales Volume by Application (2018-2023)
-
Table Southwest China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Cancer Biologics Production Volume by Type (2018-2023)
-
Table Northwest China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Cancer Biologics Production Volume Share by Type (2018-2023)
-
Table Northwest China Cancer Biologics Sales Volume by Application (2018-2023)
-
Table Northwest China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Cancer Biologics Sales Volume Share by Application (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Cancer Biologics Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Cancer Biologics Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Cancer Biologics Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Cancer Biologics Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Cancer Biologics Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Cancer Biologics Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Cancer Biologics Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Cancer Biologics Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Cancer Biologics Revenue, Price and Gross (2018-2023)
-
